Takeda Pharmaceutical
TAK
#491
Rank
C$65.54 B
Marketcap
C$19.70
Share price
0.28%
Change (1 day)
3.67%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$68.68 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total liabilities are C$68.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Takeda Pharmaceutical - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31C$70.19 B0.31%
2024-03-31C$69.97 B-9.28%
2023-03-31C$77.13 B0.26%
2022-03-31C$76.93 B-12.33%
2021-03-31C$87.75 B-17.2%
2020-03-31C$105.98 B2.41%
2019-03-31C$103.49 B308.51%
2018-03-31C$25.33 B-11.66%
2017-03-31C$28.68 B36.98%
2016-03-31C$20.93 B-5.24%
2015-03-31C$22.09 B1.72%
2014-03-31C$21.72 B17.46%
2013-03-31C$18.49 B6.69%
2012-03-31C$17.33 B129.33%
2011-03-31C$7.55 B6.83%
2010-03-31C$7.07 B-21.44%
2009-03-31C$9.00 B72.42%
2008-03-31C$5.22 B-13.09%
2007-03-31C$6.00 B-13.28%
2006-03-31C$6.93 B13.02%
2005-03-31C$6.13 B-12.28%
2004-03-31C$6.98 B14.01%
2003-03-31C$6.13 B-6.02%
2002-03-31C$6.52 B5.19%
2001-03-31C$6.20 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$157.27 B 128.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$91.46 B 33.16%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
C$160.17 B 133.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$86.62 B 26.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
C$1.50 B-97.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$2.80 B-95.92%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
C$111.53 B 62.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$84.89 B 23.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$107.54 B 56.57%๐Ÿ‡บ๐Ÿ‡ธ USA